California's Proposition 38 seeks to allocate $8.4 billion for medical research, but half of those funds are earmarked for a single, unnamed entity. Analysis suggests the ballot's specific requirements are designed to benefit the California Institute for Immunology and Immunotherapy.
The $4 billion carve-out for an unnamed nonprofit
Proposition 38 is presented to voters as a sweeping effort to fund cures for Alzheimer’s, cancer , and heart disease. However, as a CalMatters analysis shows, the $8.4 billion bond is split into two distinct paths: over $4 billion is designated for a single, unnamed institute, while the remaining $4 billion is set aside for competitive grants available to various public university researchers and nonprofits.
This structural split creates a curious dynamic where the majority of the funding is not subject to the same competitive rigor as the rest of the bond.. By omitting the name of the primary recipient from the ballot text, the measure avoids explicitly stating that a massive portion of public debt is being directed toward one specific organization.
How UCLA's affiliation triggers the Prop 38 windfall
The ballot language does not name the recipient, but it provides a set of highly restrictive criteria that effectively act as a fingerprint. to qualify for the $4 billion, the recipient must focus specifically on immunology and immunotherapy and be affiliated with a University of California campus medical center that meets a specific patient-volume threshold. According to the report, only one entity in the state currently satisfies these requirements.
Phil Hampton, a spokesperson for UCLA, confirmed that the California Institute for Immunology and Immunotherapy is the only nonprofit affiliated with UCLA capable of meeting the stipulations of Proposition 38. This suggests the legal language was not written to find a qualified partner, but rather to describe the California Institute for Immunology and Immunotherapy without using its name.
Gary K. Michelson's $8.2 million bet on the ballot
The financial architecture of the proposition is closely tied to Gary K. Michelson, a co-founder and board chair of the California Institute for Immunology and Immunotherapy. Michelson has already invested at least $120 million into the institute since it became a nonprofit in 2022. Now, he is leveraging his wealth to secure public funding for the same entity.
The scale of this influence is evident in the campaign spending. Gary K. Michelson and his nonprofit,the Michelson Center For Public Policy, have contributed at least $8 .2 million to the "Yes on Proposition 38" campaign. This creates a circular flow of capital where a private donor funds the campaign to pass a public bond that then funds his own private institute.
A gamble on voter apathy similar to Proposition 34
The strategy behind the vague language may be a calculated bet that voters will not scrutinize the fine print. Sarah Hill, a political science professor at Cal State Fullerton, notes that the language is "oddly specific with numbers," a tactic that often flies under the radar of the general public. Hill suggests that voters may support the measure simply because it promotes research into recognizable, feared diseases.
This pattern echoes the 2024 passage of Proposition 34, which passed by a narrow margin of 50.9% despite being a confusing measure that targeted a specific entity. The backers of Proposition 38 appear to be relying on a similar lack of voter scrutiny to push through a targeted payout under the guise of a general public benefit.
Robert Kaplan's warning about California's broader research talent
The concentration of funds has drawn criticism from the scientific community. Robert Kaplan, a former associate director at the National Institutes of Health, argues that earmarking half of the bond for one institute is fundamentally unfair. Kaplan points out that California possesses a vast array of talent in immunotherapy research that is currently "scrambling" for resources.
This raises a critical question: why was a competitive bidding process not established for the entire $8.4 billion? Furthermore, the source reports only the perspective of the "Yes" campaign and its critics; it remains unclear if other UC-affiliated institutes attempted to challenge the criteria or if there are other unnamed stakeholders benefiting from the bond's structure.
Comments 0